ChemoMetec A/S Stock
Stocks
CHEMM
DK0060055861
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 567.50 DKK | -2.16% |
|
+8.51% | -17.45% |
| 09-17 | Berenberg cuts Chemometec price target to 640 Danish kroner (650), reiterates buy | FW |
| 09-14 | Arctic cuts its price target for Chemometec to 570 Danish kroner (590), reiterates buy - BN | FW |
| Market Cap | 9.76B 1.46B 1.31B 1.22B 1.11B 2.08B 141B 2.1B 14.64B 5.72B 71.88B 5.49B 5.37B 231B | P/E 2027 * |
43.9x | P/E 2028 * | 33.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.37B 1.4B 1.25B 1.17B 1.06B 2B 136B 2.01B 14.04B 5.49B 68.97B 5.26B 5.15B 222B | EV / Sales 2027 * |
16.5x | EV / Sales 2028 * | 13.5x |
| Free-Float |
96.27% | Yield 2027 * |
0.62% | Yield 2028 * | 0.7% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| CHEMM | Delayed | |
CBOE
| CHEMMc | Real-time | |
|
Tradegate
| CHY | Real-time | |
|
Deutsche Boerse AG
| CHY | Delayed | |
|
Boerse Muenchen
| CHY | Real-time | |
|
London S.E.
| 0DZ0 | Delayed | |
|
CBOE
| 0DZ0 | Real-time | |
|
Börse Stuttgart
| CHY | Delayed |
Last Transcript: ChemoMetec A/S
| 1 day | -2.16% | ||
| 1 week | +8.51% | ||
| Current month | +8.51% | ||
| 1 month | +10.62% | ||
| 3 months | +40.12% | ||
| 6 months | +93.42% | ||
| Current year | -17.45% |
| 1 week | 508 |  | 607 |
| 1 month | 464.4 | | 607 |
| Current year | 235.2 | | 732.5 |
| 1 year | 235.2 | | 804 |
| 3 years | 235.2 | | 804 |
| 5 years | 235.2 | | 1,081 |
| 10 years | 25.4 | | 1,149 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 34 | 2024-03-12 | |
| Director of Finance/CFO | 34 | 2026-08-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2013-09-30 | |
Peter Reich
BRD | Director/Board Member | 64 | 2014-09-30 |
Kristine Færch
BRD | Director/Board Member | 50 | 2020-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/7/25 | Buy | Chief Executive Officer | 1,467 | 0.0084% | ||
| 11/7/25 | Buy | Chief Financial Officer | 350 | 0.0020% | ||
| 11/7/25 | Buy | Chief Executive Officer | 1,467 | 0.0084% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | +8.51% | -18.35% | +75.26% | 1.46B | |
| +0.58% | -0.10% | -25.78% | +1.91% | 171B | |
| -1.81% | -0.90% | -13.04% | +12.34% | 109B | |
| -1.01% | +0.00% | -25.41% | +3.59% | 106B | |
| -0.03% | +0.72% | -46.94% | -10.61% | 75.43B | |
| +0.28% | +5.66% | +2.77% | +72.56% | 60.54B | |
| -0.18% | +6.40% | +11.24% | +66.10% | 53.16B | |
| -0.08% | +0.65% | -6.42% | -31.35% | 49.07B | |
| -1.70% | -2.97% | -19.23% | +13.61% | 39.92B | |
| +1.09% | -2.31% | +27.67% | +1.30% | 31.81B | |
| Average | -0.10% | +1.58% | -11.35% | +20.47% | 69.73B | |
| Weighted average by Cap. | +0.28% | +0.69% | -16.52% | +11.93% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 569M 85.16M 76.09M 70.99M 64.48M 121M 8.24B 122M 853M 333M 4.19B 320M 313M 13.47B | 684M 102M 91.52M 85.38M 77.56M 146M 9.91B 147M 1.03B 401M 5.04B 385M 376M 16.2B |
| Net income | 225M 33.68M 30.09M 28.07M 25.5M 48.02M 3.26B 48.38M 337M 132M 1.66B 126M 124M 5.33B | 292M 43.65M 39.01M 36.39M 33.05M 62.25M 4.22B 62.72M 437M 171M 2.15B 164M 160M 6.9B |
| Net Debt | -395M -59.17M -52.87M -49.33M -44.8M -84.38M -5.72B -85.01M -593M -232M -2.91B -222M -217M -9.36B | -537M -80.33M -71.77M -66.96M -60.82M -115M -7.77B -115M -805M -314M -3.95B -302M -295M -12.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | DKK 567.50 | -2.16% | 71,114 |
| 26-10-06 | DKK 580.00 | -0.85% | 81,481 |
| 26-10-05 | DKK 585.00 | +6.27% | 173,972 |
| 26-10-02 | DKK 550.50 | +6.07% | 83,079 |
| 26-10-01 | DKK 519.00 | -0.76% | 28,137 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CHEMM Stock
Select your edition
All financial news and data tailored to specific country editions
